Breaking Down Shandong Sunway Chemical Group Co., Ltd. Financial Health: Key Insights for Investors

Peeling back the numbers on Shandong Sunway Chemical Group Co., Ltd. offers a data-rich snapshot that investors can't ignore: in the nine months to September 30, 2025 sales rose to CNY 1,941 million (up ~14.6% YoY) and trailing twelve‑month revenue stood at CNY 2.80 billion, while annual 2024 revenue was CNY 2.55 billion; profitability shows net income of CNY 153.46 million for the nine months and a TTM net income of CNY 270.16 million with a TTM net margin of ~9.6% and TTM EPS of CNY 0.41, the balance sheet and market view reveal a market cap of CNY 5.29 billion and enterprise value of CNY 4.675 billion (P/S 2.11, P/E 19.83, forward P/E 15.04), management returns include ROE of 10.3% for 2024 and a maintained dividend of CNY 0.40 per share (4.90% yield), operational context shows 810 employees with revenue per employee of CNY 3.19 million and a low beta of 0.33, and material risks and growth levers-from commodity price swings and regulatory exposure to recognition for governance and a stated ambition toward specialty chemicals expansion-frame the next chapters for this stock.

Shandong Sunway Chemical Group Co., Ltd. (002469.SZ) - Revenue Analysis

Shandong Sunway Chemical Group's top-line performance shows mixed momentum across recent periods, with notable growth in the nine‑month 2025 period but essentially flat trailing‑twelve‑month (TTM) revenue as of December 12, 2025. Key numeric highlights follow.

• Nine months ended Sep 30, 2025: Sales = CNY 1,941.0 million (+14.6% vs. CNY 1,693.27 million in the same period 2024).
• Full year 2024: Revenue = CNY 2,550.0 million (down 3.88% vs. CNY 2,650.0 million in 2023).
• TTM revenue (as of Dec 12, 2025): CNY 2.80 billion (+0.20% YoY).

• TTM revenue stability (CNY 2.80 bn, +0.20% YoY) suggests near‑term growth plateaus despite the strong nine‑month 2025 performance.
• Revenue per employee of CNY 3.19 million (810 employees) provides a productivity benchmark for peers in the chemical sector.
• P/S ratio of 2.11 and market cap CNY 5.29 billion at CNY 8.21/share indicate investor willingness to pay a premium over sales - assess against sector P/S median for context.

For background on corporate structure and how the company generates revenue, see: Shandong Sunway Chemical Group Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Shandong Sunway Chemical Group Co., Ltd. (002469.SZ) - Profitability Metrics

• Nine months ended Sep 30, 2025: net income CNY 153.46 million, up 5.1% from CNY 145.95 million a year earlier.
• Diluted EPS (9M 2025): CNY 0.2365 vs. CNY 0.2249 (9M 2024), indicating per‑share profitability improvement.
• TTM (as of Dec 12, 2025) net income: CNY 270.16 million; TTM EPS: CNY 0.41.
• TTM net profit margin: ~9.6%, signaling effective cost control and operational efficiency.
• ROE (FY 2024): 10.3%, demonstrating solid returns on shareholders' equity.
• Dividend policy: CNY 0.40 per share (yield 4.90% as of Dec 12, 2025), reflecting consistent cash distribution to investors.

• Profitability drivers: margin preservation (TTM 9.6%) combined with moderate EPS growth demonstrates resilience amid commodity and input cost volatility.
• Investor implication: steady ROE and a near‑5% yield position the company as an income‑oriented play with reasonable earnings backing.

Shandong Sunway Chemical Group Co., Ltd. (002469.SZ) - Debt vs. Equity Structure

Key market and capital-structure metrics (as of December 12, 2025):

• Equity predominance: Market cap (CNY 5.29bn) exceeds EV (CNY 4.675bn), implying a net cash position (~CNY 615m) and that equity represents the major portion of the capital base.
• Low financial leverage: The negative implied net debt suggests limited reliance on external borrowing; reported debt levels are not explicitly detailed in public sources, but the EV/market-cap relationship points to conservative leverage.
• Stability and downside protection: A beta of 0.33 signals lower volatility versus the broader market, consistent with a capital structure tilted toward equity and available cash buffers.
• Shareholder returns: The CNY 0.40 dividend (4.90% yield) reflects an active distribution policy that supports current income for investors.

Investor considerations tied to the capital mix:

• Leverage sensitivity: With implied net cash, interest-rate exposure and refinancing risk are low; major changes in debt ratios would likely come from acquisitions or large capex shifts.
• Valuation interplay: EV below market cap reduces implied enterprise-level risk and can make equity appear less leveraged when calculating multiples (EV/EBITDA, EV/Sales).
• Dividend sustainability: The 4.90% yield is meaningful for income investors, but monitoring free cash flow and payout ratio is necessary given limited public detail on gross debt.
• Risk profile: Low beta plus net cash profile generally points to defensive characteristics; sector cyclicality and commodity price exposure remain separate drivers of operating risk.

Quick reference link: Mission Statement, Vision, & Core Values (2026) of Shandong Sunway Chemical Group Co., Ltd.

Shandong Sunway Chemical Group Co., Ltd. (002469.SZ) - Liquidity and Solvency

• Reported metric availability: several standard liquidity and solvency ratios are not explicitly disclosed in the sourced public materials.
• Beta: 0.33 - indicates relatively low market volatility versus the broader market and suggests conservative financial positioning.
• Where line-item figures are missing, interpretive emphasis must rely on available public indicators (e.g., low beta) and any disclosed working capital/cash statements when accessible.

• What investors should watch next:
  • Upcoming audited financial statements for explicit current/quick ratios, debt levels, and operating cash flow figures.
  • Notes to financials detailing short-term borrowings, covenant schedules, and contingent liabilities.
  • Management commentary on capital allocation, dividend policy, and debt refinancing plans.

Shandong Sunway Chemical Group Co., Ltd. (002469.SZ) - Valuation Analysis

Current market metrics for Shandong Sunway Chemical Group Co., Ltd. (002469.SZ) indicate a valuation profile that blends moderate earnings multiples with reasonable sales-based pricing. Key figures reflect investor expectations for near-term earnings growth while aligning with peer-level valuation ranges in the chemical sector.

• Price-to-Earnings (P/E): 19.83 - investors pay ~19.83x trailing earnings per share.
• Forward P/E: 15.04 - implies anticipated earnings improvement, lowering the multiple on projected profits.
• Price-to-Sales (P/S): 2.11 - stock priced at 2.11x annual revenue per share.
• Market Capitalization: CNY 5.29 billion - reflects total equity value at the current share price.
• Share Price: CNY 8.21 - latest quoted price used in market-cap calculation.
• Enterprise Value (EV): CNY 4.675 billion - incorporates debt and cash for a capital-structure-neutral view.

Relative positioning: the combination of a sub-20 trailing P/E and a forward P/E near 15 suggests the market is pricing in recovery or margin improvement. The EV below market cap indicates net cash or low net debt on the balance sheet, strengthening enterprise-level valuation comparisons.

• Implication for investors: current multiples signal fair value with upside contingent on delivery of forecasted earnings.
• Comparative note: metrics are broadly in line with industry standards, supporting a neutral-to-favorable valuation stance.

Further investor context and stakeholder flows can be found here: Exploring Shandong Sunway Chemical Group Co., Ltd. Investor Profile: Who's Buying and Why?

Shandong Sunway Chemical Group Co., Ltd. (002469.SZ) - Risk Factors

• Regulatory and environmental compliance risk - stricter emissions, waste disposal and safety rules can lead to forced curtailments or one‑off remediation costs. A single plant suspension or retrofit can impose costs in the tens to hundreds of millions CNY and reduce annual production capacity by 5-15% in the affected product line.
• Raw material price volatility - feedstocks (e.g., benzene, methanol, cyclohexanone, coal chemicals) drive a large share of COGS. Estimated sensitivity: a 10% increase in key feedstock costs can compress gross margin by ~3-6 percentage points depending on product mix.
• Competition pressure - domestic and international producers exert pricing pressure. Market share swings of 1-3 percentage points in core product segments may translate into revenue volatility of several percentage points annually.
• Geopolitical and trade risks - export controls, tariffs or sanctions may reduce overseas sales. A 10% decline in export volumes can reduce consolidated revenue by roughly 2-6% depending on the year's export ratio.
• Technological change and R&D requirements - sustaining competitiveness requires recurring investment. Typical R&D intensity in the specialty chemical subsector is 1-3% of revenue; underinvestment risks product obsolescence and margin compression.
• Economic downturns - industrial demand is cyclical. In a moderate downturn, a 5-10% decline in end‑market demand can cut utilization rates and lead to double‑digit declines in segment EBITDA.

• Balance‑sheet and liquidity exposure - leverage and short‑term maturities magnify risk when revenues fall. Investors should watch gearing (net debt/EBITDA) and the company's available undrawn facilities; a swing in EBITDA of 20-30% can meaningfully increase leverage ratios and cost of funding.
• Supply‑chain concentration - reliance on specific suppliers or logistics routes raises single‑point failure risk. Disruption events (natural disaster, local regulation) can delay shipments and increase working capital by weeks, raising net working capital needs by several hundred million CNY in peak cases.
• Currency and commodity hedging practices - inadequate hedging exposes earnings to FX/commodity volatility. Earnings-at-risk from unhedged exposures can reach mid-single-digit percent of net profit in volatile periods.

Shandong Sunway Chemical Group Co., Ltd. (002469.SZ) - Growth Opportunities

Shandong Sunway Chemical Group Co., Ltd. (002469.SZ) is positioning itself to capture accelerated growth in specialty chemicals through a mix of strategic initiatives, governance-driven value creation and investor outreach. Key numerical targets and events underscore the company's growth narrative and appeal to investors focused on sustainable expansion.

• Revenue target: ¥10.0 billion by 2024, an explicit corporate projection that frames near-term growth expectations.
• Investor engagement: Hosting the "2025 World Investor Week" to strengthen investor relations and attract capital and strategic partners in 2025.
• Governance accolades: Recipient of the "Board of Directors Value Creation Award," signaling board-level focus on shareholder returns and long-term value.
• Recognition: Multiple acknowledgements for outstanding governance capabilities and significant value contributions, reinforcing credibility with institutional investors.

Primary growth vectors and strategic levers driving the company toward its targets:

• Specialty chemicals expansion: Focus on higher-margin specialty products to improve gross margin profile versus commodity segments.
• Sustainability transition: Investment in cleaner production and circular solutions aimed at regulatory resilience and premium pricing opportunities.
• Capacity & R&D: Targeted capacity build-outs and R&D allocation to accelerate product differentiation and reduce time-to-market for new formulations.
• Capital markets & investor relations: Proactive engagement through events like the 2025 World Investor Week to diversify investor base and lower cost of equity.

Investor-facing implications

• Visibility on targets: The ¥10 billion 2024 revenue target provides a concrete benchmark for evaluating quarterly performance and guidance revisions.
• Governance premium: Awards and repeated recognition for governance may translate into a valuation premium if operational execution aligns with board initiatives.
• Event-driven catalysis: The 2025 World Investor Week can serve as a catalyst for improved liquidity and institutional coverage if accompanied by transparent disclosure and measurable milestones.

For background on the company's origins, ownership and business model, see: Shandong Sunway Chemical Group Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money